Kayak Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $36.9M

  • Investors
  • 1

Kayak Therapeutics General Information

Description

Operator of a biotechnology company intended to harness clinical pathways and foundational research to develop innovative therapies for cancer patients. The company offers oncology-focused therapeutic development by combining diverse disciplines, datasets and clinical insights, enabling customers to access scientifically grounded, targeted cancer treatments that bring meaningful improvements in patient care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4201 Main Street
  • Suite 430
  • Houston, TX 77002
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4201 Main Street
  • Suite 430
  • Houston, TX 77002
  • United States

Kayak Therapeutics Timeline

2026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kayak Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 21-Aug-2026 $36.9M Completed Startup
1. Seed Round 26-Sep-2025 Completed Startup
To view Kayak Therapeutics’s complete valuation and funding history, request access »

Kayak Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed-2
To view Kayak Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kayak Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kayak Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capstar Capital PE/Buyout Minority
To view Kayak Therapeutics’s complete investors history, request access »

Kayak Therapeutics FAQs

  • When was Kayak Therapeutics founded?

    Kayak Therapeutics was founded in 2025.

  • Where is Kayak Therapeutics headquartered?

    Kayak Therapeutics is headquartered in Houston, TX.

  • What is the size of Kayak Therapeutics?

    Kayak Therapeutics has 7 total employees.

  • What industry is Kayak Therapeutics in?

    Kayak Therapeutics’s primary industry is Drug Discovery.

  • Is Kayak Therapeutics a private or public company?

    Kayak Therapeutics is a Private company.

  • What is Kayak Therapeutics’s current revenue?

    The current revenue for Kayak Therapeutics is .

  • How much funding has Kayak Therapeutics raised over time?

    Kayak Therapeutics has raised $43.6M.

  • Who are Kayak Therapeutics’s investors?

    Capstar Capital has invested in Kayak Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process